Drug profile

The FDA adverse-event record for Diclazuril

29 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Diclazuril. See the species affected, top reactions, and outcomes below.

29
adverse-event reports
17.2%
death-coded share
Unknown
most-reported species
10
Underfilling, Package - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
29
Total Reports
5
Deaths Reported
17.2%
Death Rate

Active Ingredients

Diclazuril

Administration Routes

UnknownOralIntravenous

Species Affected

Unknown 17
Horse 5
Chicken 4
Turkey 3

Most Affected Breeds

Unknown 17
Chicken (unknown) 3
Turkey (unknown) 3
Trakehner 1
Morgan 1
Horse (other) 1
Horse (unknown) 1
Thoroughbred 1
Chicken (other) 1

Most Reported Reactions

Underfilling, Package 10
Lack of efficacy - NOS 3
Increased mortality rate 3
Containers, Damaged 2
Underfilling, Container 2
Loose stool 2
Aggression 1
Abdominal pain 1
Death 1
Containers, Abnormal 1
Ataxia 1
Hind limb ataxia 1

Outcome Breakdown

Died
5 (41.7%)
Recovered/Normal
3 (25.0%)
Outcome Unknown
2 (16.7%)
Ongoing
1 (8.3%)
Euthanized
1 (8.3%)

Diclazuril Adverse Event Insights

29 reports name Diclazuril; 5 recorded a death outcome (17.2% of reported events, not a population-level mortality rate). Active ingredient: Diclazuril. Administration routes: Unknown, Oral, Intravenous.

By species: Unknown (17 reports), Horse (5 reports), Chicken (4 reports). By breed: Unknown (17), Chicken (unknown) (3), Turkey (unknown) (3).

Leading clinical signs: Underfilling, Package (10), Lack of efficacy - NOS (3), Increased mortality rate (3), Containers, Damaged (2). Outcome, 12 coded reports: Died leads at 41.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.